MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huss, J. M.
Right arrow Articles by Kasper, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huss, J. M.
Right arrow Articles by Kasper, C. B.

Vol. 58, Issue 1, 48-57, July 2000

Two-Stage Glucocorticoid Induction of CYP3A23 through Both the Glucocorticoid and Pregnane X Receptors

Janice M. Huss1 and Charles B. Kasper

Department of Oncology and the Environmental Toxicology Program, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin

Glucocorticoid inducibility of the CYP3A23 gene is conferred by a multisite unit comprising binding sites for several members of the nuclear receptor superfamily of transcription factors, including the chicken ovalbumin upstream promoter-transcription factor COUP-TF, pregnane X receptor (PXR), and hepatocyte nuclear factor 4 (HNF-4). The presence of three binding sites, each of which interacts with more than one factor, contributes to the complexity of the CYP3A23 glucocorticoid-responsive region. Despite the glucocorticoid sensitivity of this gene, direct binding of ligand-activated glucocorticoid receptor (GR) to the CYP3A23 dexamethasone-responsive region (DexRE) is not required for induction. This study demonstrates that DexRE-2 is the key element within the CYP3A23 proximal promoter, conferring ligand sensitivity via its interaction with the PXR/RXRalpha heterodimer. The DexRE-1 and HNF-4 sites are not ligand-responsive, but are essential accessory elements required for full promoter inducibility. In addition to ligand-mediated activation of PXR, the overall induction response involves a GR-mediated stimulation of PXR and RXRalpha expression. Hence, the induction pathway can be divided into two stages. In stage one, maximal induction requires a GR-dependent increase in PXR and RXRalpha expression, and stage two is characterized by direct transcriptional activation of CYP3A23, which is dependent on ligand-activated PXR as well as accessory factors bound at the DexRE-1 and HNF-4 sites. Because multiple proteins bind at each element within the glucocorticoid-responsive region, factors not contributing to ligand responsiveness, such as chicken ovalbumin upstream promoter-transcription factor, may modulate the response through competitive interactions.


1 Present address: Center for Cardiovascular Research, Department of Internal Medicine, Washington University School of Medicine, Box 8086, 660 S. Euclid, St. Louis, MO 63110.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
B. W. Cooper, T. M. Cho, P. M. Thompson, and A. D. Wallace
Phthalate Induction of CYP3A4 is Dependent on Glucocorticoid Regulation of PXR Expression
Toxicol. Sci., June 1, 2008; 103(2): 268 - 277.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
W. Bhadhprasit, T. Sakuma, N. Hatakeyama, M. Fuwa, K. Kitajima, and N. Nemoto
Involvement of Glucocorticoid Receptor and Pregnane X Receptor in the Regulation of Mouse CYP3A44 Female-Predominant Expression by Glucocorticoid Hormone
Drug Metab. Dispos., October 1, 2007; 35(10): 1880 - 1885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Swales, S. Kakizaki, Y. Yamamoto, K. Inoue, K. Kobayashi, and M. Negishi
Novel CAR-mediated Mechanism for Synergistic Activation of Two Distinct Elements within the Human Cytochrome P450 2B6 Gene in HepG2 Cells
J. Biol. Chem., February 4, 2005; 280(5): 3458 - 3466.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Phillips, S. R. Hood, G. G. Gibson, and N. J. Plant
IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION
Drug Metab. Dispos., February 1, 2005; 33(2): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Song, Y. Li, J. Liu, M. Mukundan, and B. Yan
Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 571 - 582.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. Z. Turncliff, P. J. Meier, and K. L. R. Brouwer
EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES
Drug Metab. Dispos., August 1, 2004; 32(8): 834 - 839.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
X. Song, M. Xie, H. Zhang, Y. Li, K. Sachdeva, and B. Yan
THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
Drug Metab. Dispos., January 1, 2004; 32(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. A. Kliewer, B. Goodwin, and T. M. Willson
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Endocr. Rev., October 1, 2002; 23(5): 687 - 702.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. L. Ripp, J. L. Fitzpatrick, J. M. Peters, and R. A. Prough
Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
Drug Metab. Dispos., May 1, 2002; 30(5): 570 - 575.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. C. Zangar, A. L. Kimzey, J. R. Okita, D. S. Wunschel, R. J. Edwards, H. Kim, and R. T. Okita
Cytochrome P450 3A Conjugation to Ubiquitin in a Process Distinct from Classical Ubiquitination Pathway
Mol. Pharmacol., April 1, 2002; 61(4): 892 - 904.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. C. Falkner, J. A. Pinaire, G.-H. Xiao, T. E. Geoghegan, and R. A. Prough
Regulation of the Rat Glutathione S-Transferase A2 Gene by Glucocorticoids: Involvement of Both the Glucocorticoid and Pregnane X Receptors
Mol. Pharmacol., September 1, 2001; 60(3): 611 - 619.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. C. Quattrochi and P. S. Guzelian
CYP3A Regulation: From Pharmacology to Nuclear Receptors
Drug Metab. Dispos., April 13, 2001; 29(5): 615 - 622.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Geick, M. Eichelbaum, and O. Burk
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
J. Biol. Chem., April 27, 2001; 276(18): 14581 - 14587.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics